Clinical features and etiology of Budd–Chiari syndrome in Chinese patients: A single‐center study

Abstract

The most prevalent etiological factor for BCS in China is membranous obstruction. Moreover, most Chinese patients with chronic BCS are treated with percutaneous transluminal angioplasty and have an excellent clinical outcome.

Use of Accessory Hepatic Vein Intervention in the Treatment of Budd–Chiari Syndrome

“…To date, most studies concentrated on TIPS or HV recanalization in the management of BCS [4][5][6][7][8][9]. In addition to three main HVs, some patients with BCS may have the compensatory accessory hepatic vein (AHV) that connects to the IVC and constitutes the drainage vessel of the liver [10][11][12].…”

“…In Western countries, anticoagulation and TIPS provide excellent outcomes in most patients [4][5][6]. In Asia, recanalization is used as the first line treatment [7][8][9].…”

Management of incidental splanchnic vein thrombosis in cancer patients

“…However, hemorrhages occur in 2.6%-33% of symptomatic SVT patients. [6][7][8][9] Therefore, it is uncertain whether anticoagulation (AC) offers net benefit. We completed a systematic rapid review to evaluate the role of AC in the treatment of hematologic and solid tumor cancer patients with incidental SVT.…”

Autosis occurs in the liver of patients with severe anorexia nervosa

“…3,[5][6][7] Idiopathic forms, combined membranous occlusion of the inferior vena cava and the hepatic veins, and higher incidence of hepatocellular carcinoma are typical features of most Chinese BCS patients. [5][6][7][8] In addition, selection of treatment modalities for BCS patients is different between China and Western countries.…”

“…3,[5][6][7] Idiopathic forms, combined membranous occlusion of the inferior vena cava and the hepatic veins, and higher incidence of hepatocellular carcinoma are typical features of most Chinese BCS patients. [5][6][7][8] In addition, selection of treatment modalities for BCS patients is different between China and Western countries. 3,9,10 Chinese patients with BCS are usually treated using percutaneous transluminal angioplasty and have a similar good clinical outcome to Western patients, who often are treated with transjugular intrahepatic portosystemic shunt plus long-term anticoagulants.…”